Please login to the form below

Not currently logged in
Email:
Password:

Novel endpoints

This page shows the latest Novel endpoints news and features for those working in and with pharma, biotech and healthcare.

J&J’s Erleada first US drug for non-metastatic prostate cancer

J&J’s Erleada first US drug for non-metastatic prostate cancer

This demonstrates the agency’s commitment to using novel endpoints to expedite important therapies to the American public," he added.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Addressing the payer-regulator evidence gap in early-stage cancer Addressing the payer-regulator evidence gap in early-stage cancer

    complications of disease whether measured symptomatically, radiographically, and increasingly with novel measurement techniques. ... endpoints that can better characterise the benefit of new drugs for early disease.

  • Novel endpoints in the digital age Novel endpoints in the digital age

    Novel regulations. Regulators have also welcomed the pharmaceutical industry’s willingness to assess therapeutic benefit using new technologies and novel endpoints. ... Encouraging and supporting the appropriate use of novel endpoints is part of this

  • Rare diseases: redefining medical communications Rare diseases: redefining medical communications

    Additionally, for many rare diseases, well-characterised efficacy endpoints are not available, so new or surrogate endpoints may need to be developed. ... Putting the patient front and centre of the development of these novel endpoints is key for the

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics